SLC7A11 and central nervous system cancer: Studies have shown that using the ferroptosis inducer erastin or directly silencing the expression of SLC7A11 protein in system Xc– induces ferroptosis in glioma cells, and increases the sensitivity of glioma cells to temozolomide, thereby promoting the killing effect of temozolomide on tumor cells[98–99].